Prevalence and type of anemia in IBD children at the time of diagnosis

Česká verzia

Authors: A. Šuláková ¹; O. Pozler ²; Nováčková L.† ³; D. Šalounová ⁴
Authors place of work: Klinika dětského lékařství, FN Ostrava, přednosta doc. MUDr. M. Hladík, Ph. D., Dětská klinika, FN Hradec Králové , přednosta prof. MUDr. M. Bayer, CSc., Ústav klinické biochemie, FN Ostrava , přednosta RNDr. Z. Švagera, Ph. D., Ekonomická f ¹
Published in the journal: Čes-slov Pediat 2012; 67 (1): 3-10.
Category: Original Papers

Summary

Introduction:
Prevalence of anemia in inflammatory bowel disease (IBD) is high and it has an important impact of anemia on the quality of life, morbidity and mortality in these patients. Iron deficiency (ID), iron deficiency anemia (IDA), anemia of chronic disease (ACD) and combination of both of these conditions represent the most frequent causes. It can be difficult to distinguish ID in condition of inflammation. In fact, the common diagnostic test (iron, ferritin and transferin saturation) are significantly influenced by inflammation and normal ferritin concentration does not exclude ID. In this case soluble transferin receptor (sTfR) and calculated sTfR/F index (sTfR/log ferritin) can improve ID diagnose.

Objective:
The aim of the study was: 1. to determine the total prevalence of anemia, 2. to determine the prevalence of the types of anemia (IDA, ACD, ACD/ID), and 3. to compare common laboratory test against sTfR and calculated sTfR/F index in diagnosis of iron deficiency in children at IBD onset.

Methods:
Fifty-six patients with newly diagnosed IBD fulfilled the inclusion criteria in the period from January 2005 to December 2009: newly diagnosed IBD and upper age limit 19 years. In all patients were examined red blood count, serum iron, total iron binding capacity, ferritin, sTfR and calculated sTfR/F index. C-reactive protein >5 mg/l was determined as a marker for inflammation. Anemia was defined by hemoglobin value <-2 SD considering age and sex. Anemic patients were divided in three groups (IDA, ACD, ACD/ID) according to the results of common tests and sTfR and sTfR/F. Both methods were subsequently compared.

Results:
Anemia was detected in 66.1% patients; significantly more frequent in Crohn’s disease (CD, 77.5%) and more frequent type of anemia were ACD and ACD/ID. Prevalence of anemia in ulcerative colitis (UC) patients was 37.5%, and there was detected only IDA. The difference in prevalence of IDA, ACD/ID and ACD between CD and UC was statistically significant. The agreement between both diagnostic methods was statistically significant in IDA (p<0.0001), the agreement in ACD/ID was reached in case of ferritin value <30 µg/l.

Conclusion:
The prevalence of anemia in IBD children is high at the onset of the disease. Soluble TfR measurement and sTfR/F index calculation can improve ID diagnosis in condition of chronic inflammation.

Key words:
anemia of chronic disease, iron deficiency anemia, iron deficiency, soluble transferin receptor, ferritin, children, inflammatory bowel disease

Zdroje

1. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel disease. Gut 2004; 53(8): 1190–1197.

2. Kulnigg S, Gasche C. Systemic review: managing in Crohn disease. Aliment Pharmacol Ther 2006; 24: 1507–1523.

3. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004 Apr5;116(Suppl): 44S–49S.

4. Suominen P, Punnonen K, Rajamäki A, et al. Serum transferin receptor and transferin receptor-ferritin index identify healthy subject with subclinical iron deficits. Blood 1998; 92(8): 2934–2939.

5. Oldenburg B, et al. Review article: Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15(4): 429–438.

6. Malope BI, et al. The ratio of serum transferin receptor and serum ferritin in the diagnosis of iron status. Br J Hematol 2001; 115: 84–89.

7. Punnonen K, et al. Serum transferin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89(3): 1052–1057.

8. Wells ChW, Lewis S, Barton, JR, et al. Effects of changes in haemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12(2): 123–130.

9. Revel-Vilk, S et al. Serum transferin receptor in children and adolescent with inflammatory bowel disease. Eur J Pediatr 2000; 159: 585–589.

10. Punnonen K, Irjala K, Rajamäki A. Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 1994; 40(5): 774–776.

11. Wians FH, et al. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferin receptor concentration. Am J Clin Pathol 2001; 115: 112–118.

12. Markovič M, et al. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest 2005; 65: 571–576.

13. Ooi Cara L, et al. Pediatric reference intervals for soluble transferrin receptor and transferrin receptore-ferritin index. World J Pediatr 2009; 5(2): 122–126.

14. Chouliarasa GL, et al. Serum transferrin receptors: distribution and diagnostic perforance in pre-school children. Blood Cells, Molecules, and Diseases 2009; 43(2): 163–168.

15. Virtanen MA, et al. Higher concentrations of serum transferrin receptor in children than in adults. Am J Clin Nutr 1999; 69: 256–260.

16. Choi JW, et al. Change in transferin receptor concentrations with age. Clin Chem 1999; 45(9): 1562–1563.

17. Margetic S, et al. Soluble treansferin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis. Clin Chem Lab Med 2005; 43(3): 326–331.

18. Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA 1997; 26(12): 973–976.

19. Mast AE, et al. Clinical utility of the soluble transferin receptor and comparison with the serum ferritin in several populations. Clin Chemist 1998; 44: 45–51.

20. Malý J. Diagnostika a následná péče o děti s nespecifickými střevními záněty. Pediatrie pro Praxi 2004; 1: 7–9.

21. Mamula P, et al. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002; 34(3): 286–290.

22. Dimitriou H, Stiakaki E, Markak EA, et al. Soluble transferrin receptor levels and soluble transferin/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Acta Paediat 2000; 89: 1169–1173.

23. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci 2010; 55: 548–559.

24. Vijverman A, Piront P, Brlaiche J, Louis E. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 2006; 69(1): 1–4.

25. Pels LPM, van de Vijver E, Waalkens HJ, et al. Slow hematological recovery in children with IBD-associated anemia in cases of „Expectant Management“. JPGN 2010; 51(6): 708–713.

26. Pels LPM, van de Vijver E, Waalkens H, et al. IBD-associates anemia in children: controlling intestinal inflammation is not enough to normalize hemoglobin. Abstract P083 in the congress book reports interim results. Paris: PIBD 2009.

27. Schilling RF. Anemia of chronic disease: A misnomer (editorials). Ann Inter Med 1991;115(7): 572–573.

28. Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996; 334(7): 619–623.

29. Koulaouzidis A, Said E, Cottier R, Saeed AA. Soluble transferin receptors and iron deficiency, a step beyond ferritin. A systemic review. J Gastrointestin Liver Dis 2009; 18(3): 345–352.

30. Suominen P, Virtanen A, Lehtonen-Veromaa M, et al. Regression-based reference limits for serum transferin receptor in children 6 months to 16 years of age (technical briefs). Clin Chem 2001; 47(5): 935–937.